BloombergLean L·
Boehringer Signs Deal for Owkin AI, Joining Astra and Sanofi
Boehringer Ingelheim GmbH agreed to use Owkin’s artificial-intelligence model to help discover new oncology and immunology medicines.
Read at Bloomberg →
Boehringer Ingelheim GmbH agreed to use Owkin’s artificial-intelligence model to help discover new oncology and immunology medicines.
<iframe src="https://statesidedaily.com/embed/cluster/28ba71d24a17bc95f15601acf0433e3e19a5a27f" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Boehringer Signs Deal for Owkin AI, Joining Astra and Sanofi"></iframe>